Clarivate and CAPES Forge Expanded Partnership for Research in Brazil
Clarivate and CAPES Significantly Expand Partnership
On June 2, 2025, Clarivate Plc, a global leader in transformative intelligence, announced the renewal and expansion of its partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) aimed at enhancing academic and healthcare research across Brazil. This renewed agreement is set to increase institutional coverage by a remarkable 57%, allowing more than 400 Brazilian institutions to access trusted research and innovation tools.
CAPES, under Brazil's Ministry of Education, plays a crucial role in advancing postgraduate education and facilitating international collaboration in science. The partnership with Clarivate, which dates back to 2001, has historically integrated essential resources into the CAPES Portal, allowing researchers easy access to vital data. The latest agreement enhances this collaboration, providing improvements to services such as the Web of Science, Journal Citation Reports, and Cortellis Drug Discovery Intelligence.
This initiative not only increases accessibility to quality research materials but also encourages academic professionals, including scholars, policy advisors, and biomedical experts, to innovate in their respective fields. The provision of comprehensive insights promotes the development of new treatments, enhances patient care, and drives informed policymaking. Matti Shem Tov, CEO of Clarivate, emphasized the significance of this partnership as a catalyst for accelerating research and innovation across Brazil. He stated, "We’re proud to support the momentum of scientific excellence in Brazil, providing researchers with the data and insights necessary to make a significant impact."
Denise Pires de Carvalho, President of CAPES, highlighted the importance of equitable resource distribution, stating, "This collaboration enables us to gain a clearer understanding of Brazilian institutions' scientific output profiles and supports decisions aimed at reducing regional disparities in research capabilities. Many researchers, particularly in newer regions such as the North and Northeast, often lack access to necessary resources for their research visibility. Expanding access can make a substantial difference in their work."
As part of the renewed partnership, new coverage will allow institutions throughout Brazil, including those in remote areas, to leverage essential research tools. These tools will foster improvements in postgraduate programs, increase innovation, and enhance the global visibility of Brazilian research outputs.
The agreement aims to democratize access to critical scientific information across Brazil's academic landscape, enabling more inclusive research practices. Through resources such as the Web of Science and the Derwent Innovation Index, institutions will gain valuable insights into global research trends and publication impacts, allowing them to benchmark their performance and support policy development more effectively.
Furthermore, with the expanded access to Cortellis Drug Discovery Intelligence, Brazil’s life sciences professionals will benefit from enriched insights into biology, pharmacology, and chemistry. Users will be better equipped to navigate the research and development lifecycle, aiding in more informed decision-making among biomedical researchers and educators.
Clarivate’s collaboration with CAPES vividly illustrates the power of strategic partnerships in fostering a connected and high-performing research ecosystem. By expanding access to trusted data and insights, the partnership sets a foundation for fruitful collaborations among academic institutions, enabling Brazil to enhance its stature globally in research and innovation. For detailed information about this partnership with CAPES and the array of solutions available via this renewed collaboration, visit the Clarivate website.
Brazil's scientific output is characterized by a strong emphasis on Sustainable Development Goals (SDGs) and international collaboration, making this partnership timely and strategically significant for the nation's research landscape. As Brazil continues to grow its scientific identity, this partnership is poised to play a critical role in shaping high-quality research and innovation that benefits not just the nation but also the international community.